4Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med,1995,332(24):1589-1593.
5Di Nunno L, Larsson LG, Rinehart JJ, et al. Estrogen and progesterone receptors in non-small cell lung cancer in 248 consecutive patients who underwent surgical resection. Arch Pathol Lab Med,2000,124(10):1467-1470.
6Mollerup S, Jorgensen K, Berge G, et al. Expression of estrogen receptors alpha and beta in human lung tissue and cell lines. Lung Cancer,2002,37(2):153-159.
7Bentzen SM, Skoczylas JZ, Overgaard M, et al. Radiotherapy-related lung fibrosis enhanced by tamoxifen. J Natl Cancer Inst,1996,88(13):918-922.
8van Leeuwen FE, Benraadt J, Coebergh JW, et al. Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet,1994,343(8895):448-452.
9Millward MJ, Lien EA, Robinson A, et al. High-dose (480 mg/day) tamoxifen with etoposide: a study of a potential multi-drug resistance modulator. Oncology,1994,51(1):79-83.
10Perez EA, Gandara DR, Edelman MJ, et al. Phase Ⅰ trial of high-dose tamoxifen in combination with cisplatin in patients with lung cancer and other advanced malignancies. Cancer Invest,2003,21(1):1-6.
5Kaiser U, Hofmann J, Schilli M, et al. Steroid-hormone receptors in cell lines and tumor biopsies of human lung cancer[J]. Int J Cancer,1996, 67: 357-364.
6Ho GH, Ji CY, Phang BH, et al. Tamoxifen alters levels of serum insulin-like growth factors and binding proteins in postmenopausal breast cancer patients: a prospective paired cohort study[J]. Ann Surg Oncol, 1998, 5: 361-367.
7England GM, Jordan VC. Pure antiestrogens as a new therapy for breast cancer[J]. Oncol Res, 1997, 9: 397-402.
8Luo S, Martel C, Sourla A, et al. Comparative effects of 28-day treatment with the new antiestrogen EM-800 and tamoxifen on estrogen-sensitive parameters in intact mice[J]. Int J Cancer, 1997, 73: 381-391.
9Lonning PE. Aromatase inhibitors and their future role in post-menopausal women with early breast cancer[J]. Br J Cancer, 1998, 78: 12-15.
10Blamey RW. The role of selective non-steroidal aromatase inhibitors in future treatment strategies[J]. Oncology, 1997, 54: 27-31.
